2015 to 2018 Hypertension Prevalence Nearly 50 Percent in the United States

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 21, 2023 -- The prevalence of stage 1 and stage 2 hypertension in 2015 to 2018 was 44.2 percent in Los Angeles (LA) County and 47.3 percent in the United States, according to a report published in the November Health E-Stats, a publication of the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.

Cheryl D. Fryar, M.S.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues present the percentage of adults in LA County and the United States with stage 1 and 2 hypertension, defined according to the 2017 blood pressure cut points (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg) or currently taking blood pressure medication during 2015 to 2018.

The researchers found that for adults ages 18 years and older, the unadjusted prevalence of hypertension (stage 1 and 2) was 44.2 and 47.3 percent in LA County and the United States, respectively; after adjustment for age, the prevalence was 43.3 and 44.5 percent, respectively. The unadjusted prevalence in women was 38.4 and 44.2 percent in LA County and the United States, respectively, while in men, the corresponding prevalence was 50.4 and 50.6 percent.

The prevalence of stage 2 hypertension in LA County and the United States was 30.4 and 33.0 percent, respectively. Of those with stage 2 hypertension, 68.4 and 71.2 percent of adults in LA County and the United States, respectively, received treatment, and the prevalence of controlled hypertension was 36.5 and 46.1 percent, respectively.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords